Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-25-039704
Filing Date
2025-08-12
Accepted
2025-08-11 19:39:09
Documents
14
Period of Report
2024-12-28

Document Format Files

Seq Description Document Type Size
1 10-K/A alts-20241228.htm   iXBRL 10-K/A 82359
2 EX-97.1 exh971_alt5clawbackpolicy1.htm EX-97.1 34749
  Complete submission text file 0001628280-25-039704.txt   315548

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alts-20241228.xsd EX-101.SCH 2416
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alts-20241228_lab.xml EX-101.LAB 35732
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alts-20241228_pre.xml EX-101.PRE 20954
17 EXTRACTED XBRL INSTANCE DOCUMENT alts-20241228_htm.xml XML 4863
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19621 | Film No.: 251203520
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)